Apex Neuro Holdings, Inc. — Form D/A
Apex Neuro Holdings, Inc. of BROOKLYN, NY, a company, filed a Form D amendment with the SEC on 2019-11-26. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Other.
Offering
- Filed: 2019-11-26
- Form: D/A
- Accession: 0001783115-19-000004
- Industry: Other
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 5
- Date of first sale: 2019-10-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-352962
Issuer
- Name: Apex Neuro Holdings, Inc.
- CIK: 0001783115
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 370 JAY ST., 7TH FL., BROOKLYN, NY, 11201
- Phone: 781-698-5605
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Lis Rhodes | Executive Officer | Brooklyn, NY |
| Adam D'Augelli | Director | Boston, MA |
| Latif Peracha | Director | New York, NY |
| Robert Nelsen | Director | Seattle, WA |
| Zen Chu | Director | Brooklyn, NY |
| Hunter Bergschneider | Executive Officer | Brooklyn, NY |
| Francois Kress | Director | Brooklyn, NY |
| Francois Kress | Executive Officer | Brooklyn, NY |
| Adam D?Augelli | Director | Brooklyn, NY |
Other filings by this issuer (2)
More